United States Supreme Court (1 summary)
Merck Sharp & Dohme Corp. v. Albrecht
Absence of “clear evidence that the FDA would not approve a change to a label, the Court will not conclude that it was impossible… to comply with both federal and state requirements.”
Area(s) of Law:- Preemption